Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0N0JE
|
||||
| Former ID |
DIB004014
|
||||
| Drug Name |
UP-275-22
|
||||
| Indication | Hypertension [ICD9: 401; ICD10:I10-I16] | Terminated | [545814] | ||
| Company |
Laboratories UPSA
|
||||
| Canonical SMILES |
c12nc(c(c(n1ncn2)CCCC)Cc1ccc(c2c(c3nnn[nH]3)cccc2)cc1)O
|
||||
| CAS Number |
CAS 186616-16-0
|
||||
| Target and Pathway | |||||
| Target(s) | Type-1 angiotensin II receptor | Target Info | Modulator | [543777] | |
| NetPath Pathway | TGF_beta_Receptor Signaling Pathway | ||||
| Pathway Interaction Database | Arf6 trafficking events | ||||
| Arf6 signaling events | |||||
| Angiopoietin receptor Tie2-mediated signaling | |||||
| PathWhiz Pathway | Angiotensin Metabolism | ||||
| Muscle/Heart Contraction | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.